{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:52:17Z","timestamp":1793922737784,"version":"4.8.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,8,26]],"date-time":"2011-08-26T00:00:00Z","timestamp":1314316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00228-011-1108-2","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T02:56:18Z","timestamp":1314240978000},"page":"213-217","source":"Crossref","is-referenced-by-count":130,"title":["Repeated administration of berberine inhibits cytochromes P450 in humans"],"prefix":"10.1007","volume":"68","author":[{"given":"Ying","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-rong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis D.","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,26]]},"reference":[{"issue":"10","key":"1108_CR1","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1517\/13543784.2010.517745","volume":"19","author":"PR Vuddanda","year":"2010","unstructured":"Vuddanda PR, Chakraborty S, Singh S (2010) Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs 19(10):1297\u20131307. doi: 10.1517\/13543784.2010.517745","journal-title":"Expert Opin Investig Drugs"},{"key":"1108_CR2","first-page":"1","volume":"12","author":"PM Barnes","year":"2008","unstructured":"Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 12:1\u201323","journal-title":"Natl Health Stat Report"},{"issue":"8","key":"1108_CR3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00228-005-0952-3","volume":"61","author":"X Wu","year":"2005","unstructured":"Wu X, Li Q, Xin H, Yu A, Zhong M (2005) Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol 61(8):567\u2013572. doi: 10.1007\/s00228-005-0952-3","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"1108_CR4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1055\/s-2007-981550","volume":"73","author":"AS Etheridge","year":"2007","unstructured":"Etheridge AS, Black SR, Patel PR, So J, Mathews JM (2007) An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Planta Med 73(8):731\u2013741. doi: 10.1055\/s-2007-981550","journal-title":"Planta Med"},{"issue":"5","key":"1108_CR5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/pgs.09.22","volume":"10","author":"A Gunes","year":"2009","unstructured":"Gunes A, Ozbey G, Vural EH, Uluoglu C, Scordo MG, Zengil H, Dahl ML (2009) Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population. Pharmacogn 10(5):769\u2013778. doi: 10.2217\/pgs.09.22","journal-title":"Pharmacogn"},{"issue":"5","key":"1108_CR6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.clpt.6100187","volume":"82","author":"JY Ryu","year":"2007","unstructured":"Ryu JY, Song IS, Sunwoo YE, Shon JH, Liu KH, Cha IJ, Shin JG (2007) Development of the \"Inje cocktail\" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo. Clin Pharmacol Ther 82(5):531\u2013540. doi: 10.1038\/sj.clpt.6100187","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"1108_CR7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1067\/mcp.2003.14","volume":"73","author":"XP Chen","year":"2003","unstructured":"Chen XP, Tan ZR, Huang SL, Huang Z, Ou-Yang DS, Zhou HH (2003) Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects. Clin Pharmacol Ther 73(3):264\u2013271. doi: 10.1067\/mcp.2003.14","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1108_CR8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12272-010-0209-2","volume":"33","author":"J Zheng","year":"2010","unstructured":"Zheng J, Chen B, Jiang B, Zeng L, Tang ZR, Fan L, Zhou HH (2010) The effects of puerarin on CYP2D6 and CYP1A2 activities in vivo. Arch Pharm Res 33(2):243\u2013246. doi: 10.1007\/s12272-010-0209-2","journal-title":"Arch Pharm Res"},{"issue":"10","key":"1108_CR9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1080\/00498250903134435","volume":"39","author":"Z Li","year":"2009","unstructured":"Li Z, Wang G, Wang LS, Zhang W, Tan ZR, Fan L, Chen BL, Li Q, Liu J, Tu JH, Hu DL, Liu ZQ, Zhou HH (2009) Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects. Xenobiotica 39(10):788\u2013793. doi: 10.1080\/00498250903134435","journal-title":"Xenobiotica"},{"issue":"3","key":"1108_CR10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.clpt.2003.09.014","volume":"75","author":"LS Wang","year":"2004","unstructured":"Wang LS, Zhou G, Zhu B, Wu J, Wang JG, Abd El-Aty AM, Li T, Liu J, Yang TL, Wang D, Zhong XY, Zhou HH (2004) St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin Pharmacol Ther 75(3):191\u2013197. doi: 10.1016\/j.clpt.2003.09.014","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"1108_CR11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1440-1681.2009.05158.x","volume":"36","author":"Y Chen","year":"2009","unstructured":"Chen Y, Xiao P, Ou-Yang DS, Fan L, Guo D, Wang YN, Han Y, Tu JH, Zhou G, Huang YF, Zhou HH (2009) Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers. Clin Exp Pharmacol Physiol 36(8):828\u2013833. doi: 10.1111\/j.1440-1681.2009.05158.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"1108_CR12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00228-010-0814-5","volume":"66","author":"JH Tu","year":"2010","unstructured":"Tu JH, He YJ, Chen Y, Fan L, Zhang W, Tan ZR, Huang YF, Guo D, Hu DL, Wang D, Hong-Hao Z (2010) Effect of glycyrrhizin on the activity of CYP3A enzyme in humans. Eur J Clin Pharmacol 66(8):805\u2013810. doi: 10.1007\/s00228-010-0814-5","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1108_CR13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/FTD.0b013e318197e1bf","volume":"31","author":"S Ghassabian","year":"2009","unstructured":"Ghassabian S, Chetty M, Tattam BN, Chem MC, Glen J, Rahme J, Stankovic Z, Ramzan I, Murray M, McLachlan AJ (2009) A high-throughput assay using liquid chromatography-tandem mass spectrometry for simultaneous in vivo phenotyping of 5 major cytochrome p450 enzymes in patients. Ther Drug Monit 31(2):239\u2013246. doi: 10.1097\/FTD.0b013e318197e1bf","journal-title":"Ther Drug Monit"},{"issue":"1","key":"1108_CR14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2002.121216","volume":"71","author":"U Yasar","year":"2002","unstructured":"Yasar U, Forslund-Bergengren C, Tybring G, Dorado P, Llerena A, Sjoqvist F, Eliasson E, Dahl ML (2002) Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype. Clin Pharmacol Ther 71(1):89\u201398. doi: 10.1067\/mcp.2002.121216","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1108_CR15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004714-199904000-00011","volume":"19","author":"CL Alfaro","year":"1999","unstructured":"Alfaro CL, Lam YW, Simpson J, Ereshefsky L (1999) CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline. J Clin Psychopharmacol 19(2):155\u2013163","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"1108_CR16","first-page":"608","volume":"13","author":"LH Yang","year":"2005","unstructured":"Yang LH, Lu FE, Dong H, Xu LJ, Wang KF (2005) Effect of emodin and berberine on gastrointestinal motility in type 2 diabetic rats. World Chin J Digestol 13(5):608\u2013611","journal-title":"World Chin J Digestol"},{"issue":"6","key":"1108_CR17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/0091270007312153","volume":"48","author":"SM Huang","year":"2008","unstructured":"Huang SM, Strong JM, Zhang L, Reynolds KS, Nallani S, Temple R, Abraham S, Habet SA, Baweja RK, Burckart GJ, Chung S, Colangelo P, Frucht D, Green MD, Hepp P, Karnaukhova E, Ko HS, Lee JI, Marroum PJ, Norden JM, Qiu W, Rahman A, Sobel S, Stifano T, Thummel K, Wei XX, Yasuda S, Zheng JH, Zhao H, Lesko LJ (2008) New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J Clin Pharmacol 48(6):662\u2013670. doi: 10.1177\/0091270007312153","journal-title":"J Clin Pharmacol"},{"key":"1108_CR18","doi-asserted-by":"crossref","unstructured":"Guo Y, Li F, Ma XC, Cheng XG, Zhou HH, Klaassen CD (2011) CYP2D plays a major role in berberine metabolism in liver of mice and humans. Xenobiotica. doi: 10.3109\/00498254.2011.597456","DOI":"10.3109\/00498254.2011.597456"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-011-1108-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1108-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T07:21:48Z","timestamp":1560496908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-011-1108-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,26]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1108"],"URL":"https:\/\/doi.org\/10.1007\/s00228-011-1108-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,26]]}}}